359 related articles for article (PubMed ID: 29378675)
1. Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres.
Povedano JM; Martinez P; Serrano R; Tejera Á; Gómez-López G; Bobadilla M; Flores JM; Bosch F; Blasco MA
Elife; 2018 Jan; 7():. PubMed ID: 29378675
[TBL] [Abstract][Full Text] [Related]
2. Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence.
Liu T; Gonzalez De Los Santos F; Zhao Y; Wu Z; Rinke AE; Kim KK; Phan SH
J Biol Chem; 2019 May; 294(22):8861-8871. PubMed ID: 31000627
[TBL] [Abstract][Full Text] [Related]
3. AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Muñoz-Lorente MA; Martínez P; Tejera Á; Whittemore K; Moisés-Silva AC; Bosch F; Blasco MA
PLoS Genet; 2018 Aug; 14(8):e1007562. PubMed ID: 30114189
[TBL] [Abstract][Full Text] [Related]
4. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.
Bär C; Povedano JM; Serrano R; Benitez-Buelga C; Popkes M; Formentini I; Bobadilla M; Bosch F; Blasco MA
Blood; 2016 Apr; 127(14):1770-9. PubMed ID: 26903545
[TBL] [Abstract][Full Text] [Related]
5. Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction.
Povedano JM; Martinez P; Flores JM; Mulero F; Blasco MA
Cell Rep; 2015 Jul; 12(2):286-99. PubMed ID: 26146081
[TBL] [Abstract][Full Text] [Related]
6. Telomerase and telomere length in pulmonary fibrosis.
Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
[TBL] [Abstract][Full Text] [Related]
7. Short telomeres in pulmonary fibrosis: from genetics to clinical significance.
Trăilă D; Mlădinescu OF; Oancea C; Tudorache V
Pneumologia; 2015; 64(1):8, 11-3. PubMed ID: 26016050
[TBL] [Abstract][Full Text] [Related]
8. Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.
Piñeiro-Hermida S; Autilio C; Martínez P; Bosch F; Pérez-Gil J; Blasco MA
J Cell Biol; 2020 Oct; 219(10):. PubMed ID: 32777016
[TBL] [Abstract][Full Text] [Related]
9. Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis.
Naikawadi RP; Disayabutr S; Mallavia B; Donne ML; Green G; La JL; Rock JR; Looney MR; Wolters PJ
JCI Insight; 2016 Sep; 1(14):e86704. PubMed ID: 27699234
[TBL] [Abstract][Full Text] [Related]
10. Short telomeres are a risk factor for idiopathic pulmonary fibrosis.
Alder JK; Chen JJ; Lancaster L; Danoff S; Su SC; Cogan JD; Vulto I; Xie M; Qi X; Tuder RM; Phillips JA; Lansdorp PM; Loyd JE; Armanios MY
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13051-6. PubMed ID: 18753630
[TBL] [Abstract][Full Text] [Related]
11. Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice.
Whittemore K; Derevyanko A; Martinez P; Serrano R; Pumarola M; Bosch F; Blasco MA
Aging (Albany NY); 2019 May; 11(10):2916-2948. PubMed ID: 31140977
[TBL] [Abstract][Full Text] [Related]
12. Short telomeres in alveolar type II cells associate with lung fibrosis in post COVID-19 patients with cancer.
Martínez P; Sánchez-Vazquez R; Saha A; Rodriguez-Duque MS; Naranjo-Gonzalo S; Osorio-Chavez JS; Villar-Ramos AV; Blasco MA
Aging (Albany NY); 2023 Jun; 15(11):4625-4641. PubMed ID: 37294548
[TBL] [Abstract][Full Text] [Related]
13. Telomere shortening in familial and sporadic pulmonary fibrosis.
Cronkhite JT; Xing C; Raghu G; Chin KM; Torres F; Rosenblatt RL; Garcia CK
Am J Respir Crit Care Med; 2008 Oct; 178(7):729-37. PubMed ID: 18635888
[TBL] [Abstract][Full Text] [Related]
14. Telomeres in lung diseases.
Calado RT
Prog Mol Biol Transl Sci; 2014; 125():173-83. PubMed ID: 24993703
[TBL] [Abstract][Full Text] [Related]
15. Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs.
Chen R; Zhang K; Chen H; Zhao X; Wang J; Li L; Cong Y; Ju Z; Xu D; Williams BR; Jia J; Liu JP
J Biol Chem; 2015 Dec; 290(52):30813-29. PubMed ID: 26518879
[TBL] [Abstract][Full Text] [Related]
16. Telomere length is a determinant of emphysema susceptibility.
Alder JK; Guo N; Kembou F; Parry EM; Anderson CJ; Gorgy AI; Walsh MF; Sussan T; Biswal S; Mitzner W; Tuder RM; Armanios M
Am J Respir Crit Care Med; 2011 Oct; 184(8):904-12. PubMed ID: 21757622
[TBL] [Abstract][Full Text] [Related]
17. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
19. A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.
Le Saux CJ; Davy P; Brampton C; Ahuja SS; Fauce S; Shivshankar P; Nguyen H; Ramaseshan M; Tressler R; Pirot Z; Harley CB; Allsopp R
PLoS One; 2013; 8(3):e58423. PubMed ID: 23516479
[TBL] [Abstract][Full Text] [Related]
20. Conditional Knockout of Telomerase Reverse Transcriptase in Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis.
Liu T; Yu H; Ding L; Wu Z; Gonzalez De Los Santos F; Liu J; Ullenbruch M; Hu B; Martins V; Phan SH
PLoS One; 2015; 10(11):e0142547. PubMed ID: 26555817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
